USPTO serial 79364693
T-PORT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SEVERSON, JUSTIN
- Law office
- TMO LAW OFFICE 111
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with T-PORT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Alexander Lazouski
Alexander Lazouski Lazouski IP LLCSuite 1, 14726 Bowfin Ter.Lakewood Ranch, FL 34202UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Medical and veterinary apparatus and instruments, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; medical apparatus and instruments, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; surgical apparatus and instruments; diagnostic, examination, and monitoring equipment, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; diagnostic apparatus for medical purposes, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; tools for medical diagnostics, namely, apparatus for providing transcutaneous access to the blood circulation and the gastrointestinal tract; apparatus for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; medical apparatus for preparing access to the bloodstream and gastrointestinal tract; medical apparatus for dosing of drugs and nutrients to the bloodstream and gastrointestinal tract; valves for medical apparatus and instruments for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; implantable medical apparatus and instruments, namely implantable access device for providing transcutaneous access to the blood circulation and the gastrointestinal tract and for transcutaneous dosing of medicines and nutrients to the blood circulation and the gastrointestinal tract; catheter skin anchor medical instruments; medical devices for placing and securing catheters | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 16, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 16, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 29, 2025 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 12, 2025 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 12, 2025 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 24, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 12, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 12, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 7, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 7, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 29, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 29, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 9, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 8, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 8, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 31, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 8, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 8, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 18, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 14, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 14, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 10, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2023 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |